Search Market Research Report

Discover Our Latest Reports
Discover Our Featured Reports
Discover Top Selling Reports

Extracorporeal Membrane Oxygenation Market Size, Share Global Analysis Report, 2020–2026

report img

Extracorporeal Membrane Oxygenation Market by Modality (Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV)), Application (Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR)): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026

Industry Insights

According to the report published by Facts & Factors, the global Extracorporeal Membrane Oxygenation market size was worth around USD 285.45 million in 2019 and is predicted to grow around USD 384.71 million by 2026 with a compound annual growth rate (CAGR) of roughly 4.4% between 2020 and 2026.

The Extracorporeal Membrane Oxygenation market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Extracorporeal Membrane Oxygenation market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the Extracorporeal Membrane Oxygenation industry. The report analyzes and declares the historical and current trends analysis of the Extracorporeal Membrane Oxygenation Industry and subsequently recommends the projected trends anticipated to be observed in the Extracorporeal Membrane Oxygenation market during the upcoming years.

Extracorporeal Membrane Oxygenation Market Size

To know more about this report | Request Free Sample Copy

logoKey Insights from Primary Research

  • Our primary respondents believed the market to observe a stable growth of 4.4% over the forecast period on account of the Growing incidence of chronic obstructive pulmonary disorder (COPD), cardiopulmonary disease, and respiratory failure around the globe will provide considerable potential for growth in timeline forecasts of extracorporeal membrane oxygenation on the world market.
  • Some of the experts predict the arteriovenous category (AV) is expected to grow at the highest CAGR in the forecast period.
  • It is projected that the Extracorporeal Membrane Oxygenation demand controls North America led by Europe. The advantageous payment situation decreased the prevalence of lung cancer, and the presence of a large number of ECMO centers in the U.S. are expected to improve the demand for North American ECMO systems.
  • The market experts suggest investing in extracorporeal membrane oxygenation market as the incidences of extracorporeal cardiopulmonary resuscitation (ECPR), respiratory diseases and cardiac diseases

logoKey Recommendations from Analysts

  • Our analysts recommend focusing on the Asia-Pacific extracorporeal membrane oxygenation market since their estimations discovered that this region turned out to be the top asset pocket across the globe.
  • The major reason behind the growth of the extracorporeal membrane oxygenation is the rising prevalence of unhealthy habits and smoking tobacco would lead to increased occurrence of respiratory disorders which will fuel market growth over the expected period of time.
  • Increasing demand for Extracorporeal Membrane Oxygenation in Europe is likely to spur the market growth in the near future.  This is majorly attributed to the transformation of conventional technologies, and rising incidences of cardiac and cancer diseases.
  • The executive summary of the report reads the total incremental opportunity underlying in the global Extracorporeal Membrane Oxygenationmarket is nearly USD 87.53million between 2020 and 2026.

logoExtracorporeal Membrane Oxygenation Market – Cost Structure

Extracorporeal Membrane Oxygenation Market

To know more about this report | Request Free Sample Copy

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Extracorporeal Membrane Oxygenation Industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Extracorporeal Membrane Oxygenation industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Extracorporeal Membrane Oxygenation market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Extracorporeal Membrane Oxygenation industry. The Extracorporeal Membrane Oxygenation market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Extracorporeal Membrane Oxygenation sector. Key strategic developments in the Extracorporeal Membrane Oxygenation market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Extracorporeal Membrane Oxygenation market are appropriately highlighted in the report.

The purchasing pattern of consumers worldwide is based on evolving technology trends. The market share is largely influenced by the software sales greatly impacted by different strata of populations

The Extracorporeal Membrane Oxygenation market research report delivers an acute valuation and taxonomy of the Extracorporeal Membrane Oxygenation industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Extracorporeal Membrane Oxygenation industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the Extracorporeal Membrane Oxygenation industry is provided for the leading economies of the world.

logoReport Scope

Report Attribute

Details

Market Size in 2019

USD 285.45 Million

Projected Market Size in 2026

USD 384.71 Million

CAGR Growth Rate

4.40% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

ALung Technologies, Inc, EUROSETS S.r.l, Getinge Group, LivaNova PLC, Medtronic plc, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., Terumo Corporation, and others.

Key Segment

By, Modality, Application, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

The Extracorporeal Membrane Oxygenation market is segmented based on modality, application, and region.  On the basis of modality segmentation, the market is classified into Venovenous (VV), Arteriovenous (AV), and venoarterial (VA). In terms of service segmentation, the market is bifurcated into extracorporeal cardiopulmonary resuscitation (ECPR), respiratory diseases, and cardiac diseases.

logoSome of the essential players operating in the Extracorporeal Membrane Oxygenation market, but not restricted to include:

  •  ALung Technologies Inc
  •  EUROSETS S.r.l
  •  Getinge Group
  •  LivaNova PLC
  •  Medtronic plc
  •  MicroPort Scientific Corporation
  •  NIPRO Corporation
  •  OriGen Biomedical Inc.
  •  Terumo Corporation
  •  XENIOS AG

The taxonomy of the Extracorporeal Membrane Oxygenation Market by its scope and segmentation is as follows:

logoGlobal Extracorporeal Membrane Oxygenation Market Disorder Type Segment Analysis

  • Anxiety Disorder
  • ADHD
  • Bipolar Disorders
  • Alcohol use disorder
  • Depression
  • Eating Disorder
  • Post-traumatic Stress Disorder(PSTD)
  • Substance Abuse Disorder
  • Schizophrenia
  • Others

logoGlobal Extracorporeal Membrane Oxygenation Market Service Segment Analysis

  • Outpatient Counselling
  • Intensive Case Management
  • Home-based Treatment Services
  • Inpatient Hospital Treatment
  • Emergency Mental Health Service
  • Others

logo Regional Segment Analysis

  • North America
    • The U.S.
    • Rest of North America
  • Europe
    • Germany
    • The U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America 
    • The Middle East and Africa

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Extracorporeal Membrane Oxygenation market – Modality Analysis
    1. 2.1. Global Extracorporeal Membrane Oxygenation Market – Modality Overview
    2. 2.2. Global Extracorporeal Membrane Oxygenation Market Share, by Modality, 2018 & 2025 (USD Million)
    3. 2.3. Venoarterial (VA)
      1. 2.3.1. Global Venoarterial (VA) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
    4. 2.4. Venovenous (VV)
      1. 2.4.1. Global Venovenous (VV) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
    5. 2.5. Arteriovenous (AV)
      1. 2.5.1. Global Arteriovenous (AV) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Extracorporeal Membrane Oxygenation market – Application Analysis
    1. 3.1. Global Extracorporeal Membrane Oxygenation Market – Application Overview
    2. 3.2. Global Extracorporeal Membrane Oxygenation Market Share, by Application, 2018 & 2025 (USD Million)
    3. 3.3. Respiratory diseases
      1. 3.3.1. Global Respiratory diseases Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
    4. 3.4. Cardiac diseases
      1. 3.4.1. Global Cardiac diseases Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
    5. 3.5. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
      1. 3.5.1. Global Extracorporeal Cardiopulmonary Resuscitation (ECPR) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Extracorporeal Membrane Oxygenation market – Regional Analysis
    1. 4.1. Global Extracorporeal Membrane Oxygenation Market Regional Overview
    2. 4.2. Global Extracorporeal Membrane Oxygenation Market Share, by Region, 2018 & 2025 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Extracorporeal Membrane Oxygenation Market size and forecast, 2016-2026
      2. 4.3.2. North America Extracorporeal Membrane Oxygenation Market, by Country, 2018 & 2025 (USD Million)
      3. 4.3.3. North America Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026
      4. 4.3.4. North America Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026
      5. 4.3.5. U.S.
      6. 4.3.6. Canada
    4. 4.4. Europe
      1. 4.4.1. Europe Extracorporeal Membrane Oxygenation Market size and forecast, 2016-2026
      2. 4.4.2. Europe Extracorporeal Membrane Oxygenation Market, by Country, 2018 & 2025 (USD Million)
      3. 4.4.3. Europe Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026
      4. 4.4.4. Europe Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026
      5. 4.4.5. Germany
      6. 4.4.6. France
      7. 4.4.7. U.K.
      8. 4.4.8. Italy
      9. 4.4.9. Spain
      10. 4.4.10. Rest of Europe
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Extracorporeal Membrane Oxygenation Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Country, 2018 & 2025 (USD Million)
      3. 4.5.3. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026
      4. 4.5.4. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026
      5. 4.5.5. China
      6. 4.5.6. Japan
      7. 4.5.7. India
      8. 4.5.8. South Korea
      9. 4.5.9. South-East Asia
      10. 4.5.10. Rest of Asia Pacific
    6. 4.6. Latin America
      1. 4.6.1. Latin America Extracorporeal Membrane Oxygenation Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Extracorporeal Membrane Oxygenation Market, by Country, 2018 & 2025 (USD Million)
      3. 4.6.3. Latin America Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026
      4. 4.6.4. Latin America Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026
      5. 4.6.5. Brazil
      6. 4.6.6. Mexico
      7. 4.6.7. Rest of Latin America
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Extracorporeal Membrane Oxygenation Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, by Country, 2018 & 2025 (USD Million)
      3. 4.7.3. The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026
      4. 4.7.4. The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026
      5. 4.7.5. GCC Countries
      6. 4.7.6. South Africa
      7. 4.7.7. Rest of Middle-East Africa
  5. CHAPTER 5. Extracorporeal Membrane Oxygenation market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. ALung Technologies, Inc
      1. 6.1.1. Company Overview
      2. 6.1.2. ALung Technologies, Inc Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. EUROSETS S.r.l
      1. 6.2.1. Company Overview
      2. 6.2.2. EUROSETS S.r.l Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Getinge Group
      1. 6.3.1. Company Overview
      2. 6.3.2. Getinge Group Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. LivaNova PLC
      1. 6.4.1. Company Overview
      2. 6.4.2. LivaNova PLC Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Medtronic plc
      1. 6.5.1. Company Overview
      2. 6.5.2. Medtronic plc Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. MicroPort Scientific Corporation
      1. 6.6.1. Company Overview
      2. 6.6.2. MicroPort Scientific Corporation Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. NIPRO Corporation
      1. 6.7.1. Company Overview
      2. 6.7.2. NIPRO Corporation Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. OriGen Biomedical, Inc.
      1. 6.8.1. Company Overview
      2. 6.8.2. OriGen Biomedical, Inc. Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Terumo Corporation
      1. 6.9.1. Company Overview
      2. 6.9.2. Terumo Corporation Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. XENIOS AG
      1. 6.10.1. Company Overview
      2. 6.10.2. XENIOS AG Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Extracorporeal Membrane Oxygenation — Industry Analysis
    1. 7.1. Extracorporeal Membrane Oxygenation Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Extracorporeal Membrane Oxygenation Market – Attractiveness Analysis
      1. 7.4.1. By Modality
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models

      List of Figures

      FIG. 1 Global Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 2 Global Extracorporeal Membrane Oxygenation Market Share, by Modality, 2018 & 2025 (USD Million)
      FIG. 3 Global Venoarterial (VA) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 4 Global Venovenous (VV) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 5 Global Arteriovenous (AV) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 6 Global Extracorporeal Membrane Oxygenation Market Share, by Application, 2018 & 2025 (USD Million)
      FIG. 7 Global Respiratory diseases Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 8 Global Cardiac diseases Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 9 Global Extracorporeal Cardiopulmonary Resuscitation (ECPR) Extracorporeal Membrane Oxygenation Market, 2016-2026 (USD Million)
      FIG. 10 Global Extracorporeal Membrane Oxygenation Market Share, by Region, 2018 & 2025
      FIG. 11 North America Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 12 U.S. Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 13 Canada Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 14 Europe Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 15 Germany Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 16 France Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 17 U.K. Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 18 Italy Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 19 Spain Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 20 Rest of Europe Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 21 Asia Pacific Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 22 China Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 23 Japan Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 24 India Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 25 South  Korea Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 26 South-East Asia Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 27 Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 28 Latin America Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 29 Brazil Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 30 Mexico Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 31 Rest of Latin America Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 32 The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 33 GCC Countries Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 34 South Africa Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 35 Rest of Middle-East Africa Extracorporeal Membrane Oxygenation Market, 2016-2026
      FIG. 36 Competitor Market Share – Revenue
      FIG. 37 ALung Technologies, Inc Revenue and Growth Rate
      FIG. 38 ALung Technologies, Inc Market Share
      FIG. 39 EUROSETS S.r.l Revenue and Growth Rate
      FIG. 40 EUROSETS S.r.l Market Share
      FIG. 41 Getinge Group Revenue and Growth Rate
      FIG. 42 Getinge Group Market Share
      FIG. 43 LivaNova PLC Revenue and Growth Rate
      FIG. 44 LivaNova PLC Market Share
      FIG. 45 Medtronic plc Revenue and Growth Rate
      FIG. 46 Medtronic plc Market Share
      FIG. 47 MicroPort Scientific Corporation Revenue and Growth Rate
      FIG. 48 MicroPort Scientific Corporation Market Share
      FIG. 49 NIPRO Corporation Revenue and Growth Rate
      FIG. 50 NIPRO Corporation Market Share
      FIG. 51 OriGen Biomedical, Inc. Revenue and Growth Rate
      FIG. 52 OriGen Biomedical, Inc. Market Share
      FIG. 53 Terumo Corporation Revenue and Growth Rate
      FIG. 54 Terumo Corporation Market Share
      FIG. 55 XENIOS AG Revenue and Growth Rate
      FIG. 56 XENIOS AG Market Share
      FIG. 57 Market Dynamics
      FIG. 58 Global Extracorporeal Membrane Oxygenation – Value Chain Analysis
      FIG. 59 Technology Roadmap and Timeline
      FIG. 60 Market Attractiveness Analysis – By Modality
      FIG. 61 Market Attractiveness Analysis – By Application
      FIG. 62 Market Attractiveness Analysis – By Region
      FIG. 63 Market Channel
      FIG. 64 Marketing Channel Development Trend
      FIG. 65 Growth in World Gross Product, 2008-2018

      List of Tables

      TABLE 1 Global Extracorporeal Membrane Oxygenation Market, 2018 & 2025 (USD Million)
      TABLE 2 Global Extracorporeal Membrane Oxygenation market, by Modality, 2016-2026 (USD Million)
      TABLE 3 Global Extracorporeal Membrane Oxygenation market, by Application, 2016-2026 (USD Million)
      TABLE 4 Global Extracorporeal Membrane Oxygenation market, by Region, 2016-2026 (USD Million)
      TABLE 5 North America Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026 (USD Million)
      TABLE 6 North America Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026 (USD Million)
      TABLE 7 Europe Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026 (USD Million)
      TABLE 8 Europe Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026 (USD Million)
      TABLE 9 Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026 (USD Million)
      TABLE 10 Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026 (USD Million)
      TABLE 11 Latin America Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026 (USD Million)
      TABLE 12 Latin America Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026 (USD Million)
      TABLE 13 The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, by Modality, 2016-2026 (USD Million)
      TABLE 14 The Middle-East and Africa Extracorporeal Membrane Oxygenation Market, by Application, 2016-2026 (USD Million)
      TABLE 15 Global Extracorporeal Membrane Oxygenation Market - Company Revenue Analysis 2016-2019 (USD Million)
      TABLE 16 Global Extracorporeal Membrane Oxygenation Market - Company Revenue Share Analysis 2016-2019(%)
      TABLE 17 Acquisitions and Mergers
      TABLE 18 New Product/Service Launch
      TABLE 19 Research & Development Activities
      TABLE 20 Market Drivers
      TABLE 21 Market Restraints
      TABLE 22 Market Opportunities

Industry Major Market Players

  •  ALung Technologies Inc
  •  EUROSETS S.r.l
  •  Getinge Group
  •  LivaNova PLC
  •  Medtronic plc
  •  MicroPort Scientific Corporation
  •  NIPRO Corporation
  •  OriGen Biomedical Inc.
  •  Terumo Corporation
  •  XENIOS AG